期刊文献+

老年高血压病患者良性小动脉性肾硬化症危险因素分析 被引量:1

A Study on Risk Factors of Benign Arteriolar Nephrosclerosis in Elderly Patients with Essential Hypertension
下载PDF
导出
摘要 目的:探讨60岁以上高血压病患者发生良性小动脉性肾硬化症(BAN)的危险因素。方法:以国内公认的诊断标准,将339例高血压病患者分为BAN组89例和对照组250例。采用病例对照研究方法,对研究对象进行单因素及多因素Logistic回归分析。结果:经单因素筛选,有18个因素与BAN有关。多因素Logistic分析,有8个因素在P=0.05水平被选入模型中,即年龄(OR=1.408)、男性(OR=3.707)、吸烟(OR=3.429)、高血压病程(OR=1.153)、脉压(OR=1.137)、尿酸(OR=1.031)、低密度脂蛋白胆固醇(LDL-C,OR=4.160)和高密度脂蛋白胆固醇(HDL-C,OR=0.014)。结论:男性、高龄、吸烟、高血压病程、脉压、尿酸和LDL-C是BAN的独立危险因素,HDL-C是BAN的独立保护因素。 Objective: To investigate the risk factors of benign arteriolar nephrosclerosis (BAN) in elderly patients (age 〉 60 years) with essential hypertension. Methods-A case-control study was conducted in 89 patients with BAN which was due to essential hypertension. The control group was 250 cases with hypertension without BAN. Available data were analyzed by mono-factorial and multi-factorial Logistic regression methods using SAS 8.1 software. Results: Eighteen factors related to BAN were identified by the mono-factorial analysis. Eight factors were selected through multiple factorial Logistic regression model at P = 0.05 level. The independent risk factors on BAN were : age (OR =1.408 ), male gender (OR = 3.707 ), smoking ( OR = 3.429 ), courses of hypertension ( OR = 1.153 ), pulse pressure ( OR = 1.137 ), uric acid ( OR = 1.031 ) and LDL-C (OR = 4.160). The independent protective factor of BAN was high density lipoprotein cholesterol (HDL-C,OR = 0.014). Conclusion:The elderly male is the high-risk population in BAN. It is long course of hypertension, smoking, high pulse pressure, and high urine acid (UA), high LDL-C and low HDL-C that may increase the risk of BAN.
出处 《天津医药》 CAS 北大核心 2009年第5期356-358,共3页 Tianjin Medical Journal
关键词 高血压 老年人 肾硬化症 危险因素 hypertension aged nephosclerosis risk factor
  • 相关文献

参考文献9

二级参考文献36

  • 1王芳,王梅,王海燕.动脉粥样硬化患者肾动脉狭窄患病率的调查[J].中华肾脏病杂志,2005,21(3):139-142. 被引量:66
  • 2Zakopiulis NA, Lekakis JP, Papamichael CM,et al. Pulse pressure in nomotensive: a marker of cantovascular disease[J]. Am J Hypertens,2001,14(3) :195-199.
  • 3Romke M,Frohlich ED. Pulse pressure,is this a chnieally useful risk factor[ J ] ? Hypertension, 1999,34(3 ) :372-374.
  • 4Safar ME, Rudnichi A, Asmar R. Drug treatment of hypertension : the reduction d pulse pressure does not necessarily parallel that a systolic and diastolic blood pressure[J]. J Hypertens,2000,18(9) :1159-1163.
  • 5Baguet FP, Mallion JM, Moreau GA,et al. Relationships between cardiovascular remodelling and the pulse pressure in never treated hypertension [ J ]. J Hum Hypertension,2000,14 ( 1 ) :23 -30.
  • 6Lindon GM, Guerin AP, Pannier B, et al. Large artery structure and function in hypertension and end-stage renal disease[ J]. J Hypertension,1998,16(12pt2) :1931-1938.
  • 7Benetos A,Safar M,Rudnichi A,et al. Pulse pressure:A predictor of long-term cardiovascular mortality in a French male population[ J ].Hypertension. 1997,30 (6) :1410-1415.
  • 8Leo KN,David EL,Kristiina N.Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men:a prospective cohort study.Arch Inter Med,2004,26:1546-1558
  • 9Donatell M,et al.Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angiograms.Am Heart J,1998,135(4):684-688
  • 10Von Eyben FE,Mouritsen E,Holm J,et al.Plasminogen activator inhibitor 1 activity and other coronary risk factors[J].Clin Appl Thromb Hemost,2005,11(1):55-61

共引文献77

同被引文献12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部